FDA Adverse Event Injury Summary report: N

ELEVOPLASTY

MDR report key: 15606903 · Received October 13, 2022

Report

Report Number
MW5112647
Event Type
Injury
Date Received
October 13, 2022
Date of Event
October 10, 2022
Report Date
October 12, 2022
Manufacturer
ZELEGENT, INC.
Product Code
LRK
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NC, US
Reporter Occupation
UNKNOWN
Health Professional
*

Narratives

Description of Event or Problem · 0

I HAD "ELEVOPLAST" FRIDAY 10/7 AND IT DID NOT GO AS PLANNED. SALES REP WAS PRESENT, BUT PRODUCT HAS FAILED TO BE ACCEPTED DESPITE CLINICAL TRIALS SUGGESTING OTHERWISE. FDA SAFETY REPORT ID # (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2242371 ELEVOPLASTY DEVICE, ANTI-SNORING LRK ZELEGENT, INC.

Patients

Seq Age Sex Outcome Treatment
1 35 YR Male ALPRAZOLAM| CETIRIZINE| DULOXETINE| LAMOTRIGINE| LOSARTAN